Patricio Serra
Name
Patricio Serra
Job title
Consultant Medical Oncologist
Email Address
the-christie.melanoma.admin@nhs.net
Phone number
of secretary/PA: 0161 446 3472
Qualifications
MD, MRes
Specialities
Medical oncology, Melanoma
Started at The Christie (Year)
2022
Responsibilities
Medical Oncology Consultant in the Melanoma Team
Professional biography
Dr Patricio Serra, MD MRes, is a Consultant Medical Oncologist at The Christie NHS Foundation Trust in Manchester. He specialises in the management of patients with melanoma.
Dr Serra completed his residency in Medical Oncology at Hospital Universitario Virgen Macarena (Seville, Spain) in 2014. In that same year, he was awarded a Sociedad Española de Oncología Médica (SEOM) Translational Research Fellowship, which brought him to Manchester in 2015 to join The Christie melanoma team as a Clinical Research Fellow. In parallel to expanding his experience in clinical research in melanoma, he also completed a Master of Research (MRes) at The University of Manchester in 2019. Dr Serra was appointed Consultant Medical Oncologist in 2022.
His research interests centre on systemic therapy for advanced melanoma, particularly immune checkpoint inhibitors (ICIs). He led a multicentre study of real-world outcomes with ICIs: ipilimumab plus nivolumab (European Journal of Cancer, 2022), and has contributed to several international collaborative studies on immunotherapy in specific populations, including patients with liver metastases, young adults, and patients whose disease has progressed on anti-PD-1 ICI therapy. He has also contributed to work on predictive clinical models and on the gut microbiome in patients treated with ICIs (Nature Medicine, 2024). He has also presented his work at national and international congresses, including ESMO.
Dr Serra is actively involved in national and international societies. He is a member of Melanoma Focus, the European Society for Medical Oncology (ESMO) and EORTC Melanoma Working Group.
Research Interest
Dr Serra's main interest is to understand the biology of melanoma, mechanisms of resistance to immunotherapy and in particular providing real-world data (how new medicines work and the outcomes after they have been approved by regulatory agencies).
Educational Interests
Dr Serra has a strong interest in medical education, supervising doctors and nurses in training.